Skip to main content
logo
OSE Immunotherapeutics SA (EPA:OSE)
France flag France · Delayed Price · Currency is EUR
4.752
-0.066 (-1.37%)
At close: Jan 30, 2026

OSE Immunotherapeutics Revenue

In the year 2025, OSE Immunotherapeutics had annual revenue of 1.78M EUR, down -97.86%. OSE Immunotherapeutics had revenue of 862.00K in the half year ending December 31, 2024, a decrease of -61.77%.

Revenue
1.78M
Revenue Growth
-95.84%
P/S Ratio
59.79
Revenue / Employee
27.84K
Employees
64
Market Cap
106.54M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.78M-81.65M-97.86%
Dec 31, 202483.44M81.21M3,646.52%
Dec 31, 20232.23M-16.08M-87.83%
Dec 31, 202218.30M-8.00M-30.43%
Dec 31, 202126.31M15.89M152.48%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cellectis70.36M
Genfit45.13M
Adocia12.88M
Fermentalg12.78M
Innate Pharma12.64M
Transgene7.58M
Sensorion5.65M
ABIONYX Pharma4.33M
Revenue Rankings

OSE Immunotherapeutics News

More News